The European Medicines Agency (EMA) has published three video animations to explain how it ensures that medicines are effective and safe for citizens across the European Economic Area (EEA).
- The first video explains that the Agency assesses, supervises and monitors medicines long before they appear in pharmacies and hospitals, and the whole time they are on the market, by bringing together the expertise from the European network.
- The second animation describes the journey of a medicine from initial laboratory tests to its authorisation by EMA and the European Commission.
- Finally, the third video focuses on how the Agency collects information on side effects from new clinical studies, scientific publications and reports from doctors, pharmacists and patients to keep medicines safe.
The videos are available on EMA’s website and on the official EMA YouTube channel.
AGE Platform Europe is involved in EMA’s work as part of its Patients and Consumers Working Parties, in which we are represented by Barbro Westerholm, from SPF, Sweden, and AGE former Vice-President.
In this group Mrs Westerholm focuses on the evaluation of medicines for older people. Indeed, clinical trials on medicines that often used by older people do not include this age group. This is a gap which has to be addressed.